ALLO
Allogene Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.19
+6.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.94x
- Price / sales
- 88.61x
- Price / cash flow
- -4.02x
Enterprise value
- Enterprise value
- $148.9M
- EV / sales
- 32.09x
- EV / EBITDA
- -0.98x
- EV / EBIT
- -0.83x
- Market cap
- $411.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026